HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$1.85
Day range
$1.71 - $1.87
Year range
$1.19 - $17.81
Market cap
93.36M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.57M | -38.87% |
Net income | -30.71M | 39.78% |
Net profit margin | — | — |
Earnings per share | -0.58 | 53.02% |
EBITDA | -32.35M | 39.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 148.57M | -21.81% |
Total assets | 185.72M | -15.63% |
Total liabilities | 48.91M | -4.76% |
Total equity | 136.81M | — |
Shares outstanding | 52.74M | — |
Price to book | 0.71 | — |
Return on assets | -40.67% | — |
Return on capital | -49.20% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -30.71M | 39.78% |
Cash from operations | -25.38M | 18.56% |
Cash from investing | 25.69M | 100.49% |
Cash from financing | 251.00K | 326.13% |
Net change in cash | 568.00K | 103.08% |
Free cash flow | -15.55M | -55.25% |
About
Founded
2015
Headquarters
Website
Employees
89
